Acne Drugs Market Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2022-27

1
Global Acne Drugs Market Research and Forecast
Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Acne Drugs Market Research Report
2022-2027 As per the latest report by IMARC
Group, titled Acne Drugs Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2022-2027, the global acne drugs market
reached a value of US 6.1 Billion in 2021.
Acne is a dermatological condition that occurs
when the hair follicles in the skin get clogged
by sebum, dead skin cells and harmful bacteria.
Although it is most common among teenagers, it
can affect people of all ages. Factors like
emotional stress, hot and humid climate and
hormonal fluctuations during puberty can cause
the onset of acne by enlarging oil glands under
the skin. Acne drugs are used for treating
bacterial infections or reduce oil production in
the skin, which helps lower the occurrence of
acne. These drugs include lifestyle remedies,
topical and oral medicines, and medical
procedures. We are regularly tracking the direct
effect of COVID-19 on the market, along with the
indirect influence of associated industries.
These observations will be integrated into the
report. Request for a PDF sample of this report
https//www.imarcgroup.com/acne-drugs-market/reque
stsample

4
Report Description and Highlights
Report Description
Global  Acne Drugs Market Trends Acne is one
of the most prevalent skin diseases globally and
is estimated to affect 9.4 of the population
worldwide. Along with this, the increasing
prevalence of skin-related diseases due to
genetic factors or heavy cosmetics has led to a
significant rise in the demand for acne drugs
across the globe. Moreover, dermatologists and
researchers are developing safer and more
advanced treatment drugs with a better
understanding of acne pathology. For instance,
Paratek and Allergen developed Sarecycline, an
oral tetracycline-class drug, for which a tablet
formulation is approved in the USA for the
treatment of inflammatory lesions of non-modular
moderate to severe acne vulgaris. Some of the
other medications prescribed by dermatologists
include topical retinoids, topical antibiotics,
azelaic acid and antibiotic tablets, which are
commonly used to treat moderate to severe acne.
Looking forward, the market is expected to grow
at a CAGR of 7.4 during the forecast period
(2022-2027) View Report TOC, Figures and
Tables https//www.imarcgroup.com/acne-drugs-mark
et

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Acne Type
• Comedonal
• Inflammatory
• Cystic
• Postsurgical/Wound
• Breakup by Drug Class
• Retinoids
• Antibiotics
• Hormonal Agents
• Combination Drugs
• Others
• Breakup by Drug Type
• OTC Drugs
• Prescription Drugs

6
Report Description and Highlights
Report Description

•  
• Breakup by Route of Administration
• Topical
• Oral
• Injectable
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
•  

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Allergan Plc
• Bausch Health Companies Inc.
• Bayer Aktiengesellschaft
• Cipher Pharmaceuticals Inc.
• Galderma Holding SA
• Johnson Johnson
• Pfizer Inc.
• Reckitt Benckiser Group Plc
• Skinvisible Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.
•  

8
Key Questions Answered in the Report
Report Description

• How has the global acne drugs market performed so
  far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the
  global acne drugs market?
• What are the key regional markets?
• What is the breakup of the market based on the
  acne type?
• What is the breakup of the market based on the
  drug class?
• What is the breakup of the market based on the
  drug type?
• What is the breakup of the market based on the
  route of administration?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global acne drugs
  market and who are the key players?
• What is the degree of competition in the
  industry? 

9
Table of Contents
Report Description
1 Preface 2 Scope and Methodology 2.1
Objectives of the Study 2.2 Stakeholders
2.3 Data Sources 2.3.1 Primary
Sources 2.3.2 Secondary Sources
2.4 Market Estimation 2.4.1
Bottom-Up Approach 2.4.2 Top-Down
Approach 2.5 Forecasting Methodology 3
Executive Summary 4 Introduction 4.1
Overview 4.2 Key Industry Trends 5
Global Acne Drugs Market 5.1 Market
Overview 5.2 Market Performance 5.3
Impact of COVID-19 5.4 Market Forecast

10
Table of Contents
Report Description
6 Market Breakup by Acne Type 6.1
Comedonal 6.1.1 Market Trends
6.1.2 Market Forecast 6.2 Inflammatory
6.2.1 Market Trends 6.2.2 Market
Forecast 6.3 Cystic 6.3.1 Market
Trends 6.3.2 Market Forecast 6.4
Postsurgical/Wound 6.4.1 Market Trends
6.4.2 Market Forecast 7 Market Breakup by
Drug Class 7.1 Retinoids 7.1.1
Market Trends Click here to visit the
complete table of content with list of figures
and tables https//www.imarcgroup.com/acne-drugs
-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us